Skip to main content
Top
Published in: Cardiology and Therapy 1/2016

Open Access 01-06-2016 | Original Research

Effects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin Resistance

Authors: Christian Cadeddu, Silvio Nocco, Lucia Cugusi, Martino Deidda, Orru Fabio, Stefano Bandino, Efisio Cossu, Michela Incani, Marco Giorgio Baroni, Giuseppe Mercuro

Published in: Cardiology and Therapy | Issue 1/2016

Login to get access

Abstract

Introduction

In patients affected by insulin resistance (IR), metformin (MET) therapy has been shown to exert its positive effects by improving glucose tolerance and preventing the evolution to diabetes. Recently, it was shown that the addition of metformin to physical training did not improve sensitivity to insulin or peak oxygen consumption (peak VO2). The purpose of this study was to establish the effect of metformin and exercise, separately or in combination, on systolic left ventricular (LV) function in individuals with IR.

Methods

Seventy-five patients with IR were enrolled and subsequently assigned to MET, combination MET and exercise, or exercise alone. The LV systolic and diastolic functions were evaluated with standard echocardiography tissue Doppler imaging (TDI) and speckle tracking echocardiography at baseline and after 12 weeks of treatment.

Results

MET, administered alone or in association with exercise, improved longitudinal LV function, as evidenced by an increase in systolic (S) wave on TDI, alongside increases in longitudinal global strain and strain rate in comparison to the group undergoing physical training alone. The traditional echocardiographic parameters showed no statistically significant differences among the three groups before or after the different cycles of therapy.

Conclusions

Treatment with MET, either with or without exercise, but not exercise alone, produced a significant increase in global longitudinal LV systolic function at rest. These findings validate the observation that the use of MET alone or in association with exercise has a crucial role to counteract the negative effects of IR on cardiovascular function.
Appendix
Available only for authorised users
Literature
1.
go back to reference Reaven GM, Lecture B. Role of insulin resistance in human disease. Diabetes. 1988;1988(37):1595–607.CrossRef Reaven GM, Lecture B. Role of insulin resistance in human disease. Diabetes. 1988;1988(37):1595–607.CrossRef
2.
go back to reference Miyatake N, Saito T, Wada J, et al. Comparison of ventilatory threshold and exercise habits between Japanese men with and without metabolic syndrome. Diabetes Res Clin Pract. 2007;77(2):314–9.CrossRefPubMed Miyatake N, Saito T, Wada J, et al. Comparison of ventilatory threshold and exercise habits between Japanese men with and without metabolic syndrome. Diabetes Res Clin Pract. 2007;77(2):314–9.CrossRefPubMed
3.
go back to reference Tuunanen H, Knuuti J. Metabolic remodelling in human heart failure. Cardiovasc Res. 2011;90:251–7.CrossRefPubMed Tuunanen H, Knuuti J. Metabolic remodelling in human heart failure. Cardiovasc Res. 2011;90:251–7.CrossRefPubMed
4.
go back to reference Ingelsson E, Sundström J, Arnlöv J, Zethelius B, Lind L. Insulin resistance and risk of congestive heart failure. JAMA. 2005;294:334–41.CrossRefPubMed Ingelsson E, Sundström J, Arnlöv J, Zethelius B, Lind L. Insulin resistance and risk of congestive heart failure. JAMA. 2005;294:334–41.CrossRefPubMed
5.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.CrossRefPubMed Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.CrossRefPubMed
6.
go back to reference Rhee MK, Herrick K, Ziemer DC, et al. Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care. 2010;33:49–54.CrossRefPubMed Rhee MK, Herrick K, Ziemer DC, et al. Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care. 2010;33:49–54.CrossRefPubMed
7.
go back to reference Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193–203.CrossRefPubMedPubMedCentral Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193–203.CrossRefPubMedPubMedCentral
8.
go back to reference Braun B, Eze P, Stephens BR, et al. Impact of metformin on peak aerobic capacity. Appl Physiol Nutr Metab. 2008;33:61–7.CrossRefPubMed Braun B, Eze P, Stephens BR, et al. Impact of metformin on peak aerobic capacity. Appl Physiol Nutr Metab. 2008;33:61–7.CrossRefPubMed
9.
go back to reference Cadeddu C, Nocco S, Deidda M, et al. Cardiopulmonary and endothelial effects of metformin treatment in an insulin resistant population. Int J Cardiol. 2012;158:302–4.CrossRefPubMed Cadeddu C, Nocco S, Deidda M, et al. Cardiopulmonary and endothelial effects of metformin treatment in an insulin resistant population. Int J Cardiol. 2012;158:302–4.CrossRefPubMed
10.
go back to reference Malin SK, Gerber R, Chipkin SR, Braun B. Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care. 2012;35:131–6.CrossRefPubMed Malin SK, Gerber R, Chipkin SR, Braun B. Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care. 2012;35:131–6.CrossRefPubMed
11.
go back to reference Cadeddu C, Nocco S, Lucia C, et al. Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients. Cardiovasc Diabetol. 2014;13:93.CrossRefPubMedPubMedCentral Cadeddu C, Nocco S, Lucia C, et al. Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients. Cardiovasc Diabetol. 2014;13:93.CrossRefPubMedPubMedCentral
12.
go back to reference Geyer H, Caracciolo G, Abe H, et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23:351–69 (quiz 453–5).CrossRefPubMed Geyer H, Caracciolo G, Abe H, et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23:351–69 (quiz 453–5).CrossRefPubMed
13.
go back to reference Ha TH, Seo H-S, Choo WJ, et al. The effect of metabolic syndrome on myocardial contractile reserve during exercise in non-diabetic hypertensive subjects. J Cardiovasc Ultrasound. 2011;19:176–82.CrossRefPubMedPubMedCentral Ha TH, Seo H-S, Choo WJ, et al. The effect of metabolic syndrome on myocardial contractile reserve during exercise in non-diabetic hypertensive subjects. J Cardiovasc Ultrasound. 2011;19:176–82.CrossRefPubMedPubMedCentral
14.
go back to reference Cadeddu C, Nocco S, Piano D, et al. Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects. Cardiovasc Diabetol. 2013;12:66.CrossRefPubMedPubMedCentral Cadeddu C, Nocco S, Piano D, et al. Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects. Cardiovasc Diabetol. 2013;12:66.CrossRefPubMedPubMedCentral
15.
go back to reference Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47:1643–9.CrossRefPubMed Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47:1643–9.CrossRefPubMed
16.
go back to reference Cadeddu C, Nocco S, Deidda M, Pau F, Colonna P, Mercuro G. Altered transmural contractility in postmenopausal women affected by cardiac syndrome X. J Am Soc Echocardiogr. 2014;27:208–14.CrossRefPubMed Cadeddu C, Nocco S, Deidda M, Pau F, Colonna P, Mercuro G. Altered transmural contractility in postmenopausal women affected by cardiac syndrome X. J Am Soc Echocardiogr. 2014;27:208–14.CrossRefPubMed
17.
go back to reference Colberg SR, Albright AL, Blissmer BJ, et al. Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc. 2010;42:2282–303.CrossRefPubMed Colberg SR, Albright AL, Blissmer BJ, et al. Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc. 2010;42:2282–303.CrossRefPubMed
18.
go back to reference Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10:165–93.CrossRefPubMed Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009;10:165–93.CrossRefPubMed
19.
go back to reference Kuznetsova T, Herbots L, Richart T, et al. Left ventricular strain and strain rate in a general population. Eur Heart J. 2008;29:2014–23.CrossRefPubMed Kuznetsova T, Herbots L, Richart T, et al. Left ventricular strain and strain rate in a general population. Eur Heart J. 2008;29:2014–23.CrossRefPubMed
20.
go back to reference de las Fuentes L, Brown AL, Mathews SJ, et al. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J. 2007;28:553–9.CrossRefPubMed de las Fuentes L, Brown AL, Mathews SJ, et al. Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J. 2007;28:553–9.CrossRefPubMed
21.
go back to reference Masugata H, Senda S, Goda F, et al. Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens Res. 2006;29:897–903.CrossRefPubMed Masugata H, Senda S, Goda F, et al. Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome. Hypertens Res. 2006;29:897–903.CrossRefPubMed
22.
23.
go back to reference Al Zadjali MA, Godfrey V, Khan F, et al. Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol. 2009;53:747–53.CrossRef Al Zadjali MA, Godfrey V, Khan F, et al. Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol. 2009;53:747–53.CrossRef
24.
go back to reference Doehner W, Rauchhaus M, Ponikowski P, et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol. 2005;46:1019–26.CrossRefPubMed Doehner W, Rauchhaus M, Ponikowski P, et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol. 2005;46:1019–26.CrossRefPubMed
26.
go back to reference Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol. 2008;51:93–102.CrossRefPubMed Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol. 2008;51:93–102.CrossRefPubMed
27.
go back to reference UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34. Lancet. 1998;352:854–65.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34. Lancet. 1998;352:854–65.CrossRef
28.
go back to reference Bethel MA, Califf RM. Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease. Am J Cardiol. 2007;99:726–31.CrossRefPubMed Bethel MA, Califf RM. Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease. Am J Cardiol. 2007;99:726–31.CrossRefPubMed
29.
go back to reference Dasgupta K, Grover SA, Da Costa D, Lowensteyn I, Yale JF, Rahme E. Impact of modified glucose target and exercise interventions on vascular risk factors. Diabetes Res Clin Pract. 2006;72:53–60.CrossRefPubMed Dasgupta K, Grover SA, Da Costa D, Lowensteyn I, Yale JF, Rahme E. Impact of modified glucose target and exercise interventions on vascular risk factors. Diabetes Res Clin Pract. 2006;72:53–60.CrossRefPubMed
30.
31.
go back to reference Wang XF, Zhang JY, Li L, Zhao XY, Tao HL, Zhang L. Metformin improves cardiac function in rats via activation of AMP-activated protein kinase. Clin Exp Pharmacol Physiol. 2011;38:94–101.CrossRefPubMed Wang XF, Zhang JY, Li L, Zhao XY, Tao HL, Zhang L. Metformin improves cardiac function in rats via activation of AMP-activated protein kinase. Clin Exp Pharmacol Physiol. 2011;38:94–101.CrossRefPubMed
32.
go back to reference Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation. 2005;111:583–90.CrossRefPubMed Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation. 2005;111:583–90.CrossRefPubMed
33.
go back to reference Salpeter SR, Buckley NS, Kahn JA, Salpeter EE. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am J Med. 2008;121(149–57):e2.PubMed Salpeter SR, Buckley NS, Kahn JA, Salpeter EE. Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am J Med. 2008;121(149–57):e2.PubMed
34.
go back to reference Wong AK, Symon R, Al Zadjali MA, et al. The effect of metformin on insulin resistance and exercise parameters in patients with heart failure. Eur J Heart Fail. 2012;14:1303–10.CrossRefPubMed Wong AK, Symon R, Al Zadjali MA, et al. The effect of metformin on insulin resistance and exercise parameters in patients with heart failure. Eur J Heart Fail. 2012;14:1303–10.CrossRefPubMed
35.
go back to reference Hughes VA, Fiatarone MA, Fielding RA, et al. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol. 1993;264:E855–62.PubMed Hughes VA, Fiatarone MA, Fielding RA, et al. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol. 1993;264:E855–62.PubMed
36.
go back to reference Koval JA, Maezono K, Patti ME, Pendergrass M, DeFronzo RA, Mandarino LJ. Effects of exercise and insulin on insulin signaling proteins in human skeletal muscle. Med Sci Sports Exerc. 1999;31:998–1004.CrossRefPubMed Koval JA, Maezono K, Patti ME, Pendergrass M, DeFronzo RA, Mandarino LJ. Effects of exercise and insulin on insulin signaling proteins in human skeletal muscle. Med Sci Sports Exerc. 1999;31:998–1004.CrossRefPubMed
37.
go back to reference Love-Osborne K, Sheeder J, Zeitler P. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr. 2008;152:817–22.CrossRefPubMedPubMedCentral Love-Osborne K, Sheeder J, Zeitler P. Addition of metformin to a lifestyle modification program in adolescents with insulin resistance. J Pediatr. 2008;152:817–22.CrossRefPubMedPubMedCentral
38.
go back to reference Snehalatha C, Mary S, Selvam S, et al. Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1). Diabetes Care. 2009;32:1796–801.CrossRefPubMedPubMedCentral Snehalatha C, Mary S, Selvam S, et al. Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1). Diabetes Care. 2009;32:1796–801.CrossRefPubMedPubMedCentral
39.
go back to reference Stewart KJ, Ouyang P, Bacher AC, Lima S, Shapiro EP. Exercise effects on cardiac size and left ventricular diastolic function: relationships to changes in fitness, fatness, blood pressure and insulin resistance. Heart. 2006;92:893–8.CrossRefPubMed Stewart KJ, Ouyang P, Bacher AC, Lima S, Shapiro EP. Exercise effects on cardiac size and left ventricular diastolic function: relationships to changes in fitness, fatness, blood pressure and insulin resistance. Heart. 2006;92:893–8.CrossRefPubMed
40.
go back to reference Ladeiras-Lopes R, Fontes-Carvalho R, Bettencourt N, Sampaio F, Gama V, Leite-Moreira AF. METformin in DIastolic Dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design: MET-DIME trial. Cardiovasc Drugs Ther. 2014;28:191–6.CrossRefPubMed Ladeiras-Lopes R, Fontes-Carvalho R, Bettencourt N, Sampaio F, Gama V, Leite-Moreira AF. METformin in DIastolic Dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design: MET-DIME trial. Cardiovasc Drugs Ther. 2014;28:191–6.CrossRefPubMed
Metadata
Title
Effects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin Resistance
Authors
Christian Cadeddu
Silvio Nocco
Lucia Cugusi
Martino Deidda
Orru Fabio
Stefano Bandino
Efisio Cossu
Michela Incani
Marco Giorgio Baroni
Giuseppe Mercuro
Publication date
01-06-2016
Publisher
Springer Healthcare
Published in
Cardiology and Therapy / Issue 1/2016
Print ISSN: 2193-8261
Electronic ISSN: 2193-6544
DOI
https://doi.org/10.1007/s40119-016-0057-3

Other articles of this Issue 1/2016

Cardiology and Therapy 1/2016 Go to the issue